Area of research
Cardiology and Cardiovascular Medicine · Pulmonary and Respiratory Medicine
Research interest
Research interests include Heart Failure Treatment and Management, Cardiac pacing and defibrillation studies, Cardiovascular Function and Risk Factors, and Electrolyte and hormonal disorders.
Interplay between medical and interventional therapies in valvular heart disease and heart failure: an expert opinion paper
European Society of Cardiology (ESC) clinical consensus statement on indications for conduction system pacing, with special contribution of the European Heart Rhythm Association of the ESC and endorsed by the Asia Pacific Heart Rhythm Society, the Canadian Heart Rhythm Society, the Heart Rhythm Society, and the Latin American Heart Rhythm Society
Clinical Management and Therapeutic Optimization of Patients with Heart Failure with Reduced Ejection Fraction and Low Blood Pressure. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC
Heart Failure Improvement, Remission, and Recovery: A <i>European Journal of Heart Failure</i> Expert Consensus Document
Pathophysiology and Clinical Use of Agents with Vasodilator Properties in Acute Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Pharmacological Treatment for Patients with Obesity and Heart Failure: Focus on Glucagon-Like Peptide-1 Receptor Agonists. <i>European Journal of Heart Failure</i> Expert Consensus Document
Epidemiology, Pathophysiology, Diagnosis and Management of Atrial Functional Mitral Regurgitation: An Expert Opinion Paper
Dietary Sodium and Fluid Intake in Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC
Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure
Right Heart Failure with Left Ventricular Assist Devices: Preoperative, Perioperative and Postoperative Management Strategies. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC
Integration of Implantable Device Therapy in Patients with Heart Failure. A Clinical Consensus Statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)
Nurse-Led Diuretic Titration Via a Point-of-Care Urinary Sodium Sensor in Patients with Acute Decompensated Heart Failure (EASY-HF): A Single-Centre, Randomized, Open-Label Study
Serum Chloride and the Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload: A Post Hoc Analysis From the ADVOR Trial
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure
Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
Worsening of Chronic Heart Failure: Definition, Epidemiology, Management and Prevention. A Clinical Consensus Statement by the Heart Failure Association of the European Society of Cardiology
Pre-Discharge and Early Post-Discharge Management of Patients Hospitalized for Acute Heart Failure: A Scientific Statement by the Heart Failure Association of the ESC
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
Acute Heart Failure and Valvular Heart Disease: A Scientific Statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
2023 <scp>HRS</scp>/<scp>APHRS</scp>/<scp>LAHRS</scp> guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure
Incidence, Risk Assessment and Prevention of Sudden Cardiac Death in Cardiomyopathies
Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice
Optimizing Outcomes in Heart Failure: 2022 and Beyond
State-of-the-Art Document on Optimal Contemporary Management of Cardiomyopathies
Hyponatraemia and Changes in Natraemia During Hospitalization for Acute Heart Failure and Associations with In-Hospital and Long-Term Outcomes – from the ESC-HFA EORP Heart Failure Long-Term Registry
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial
Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology
Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure <scp>Association of the European Society of Cardiology</scp>
Impact Analysis of Heart Failure Across European Countries: An ESC-HFA Position Paper
Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology